To avoid prolonged recovery times<\/strong>, it’s crucial that this training <\/strong>is conducted correctly and consistently<\/strong>. In this regard, professional supervision<\/strong>, for example by a healthcare provider or physiotherapist, is vital.<\/p>\n\n\n\n However, there are situations where direct supervision isn’t feasible<\/strong>, such as during the COVID-19 pandemic, which highlighted a lack of effective solutions for remote assistance<\/strong> and monitoring of rehabilitation patients.<\/p>\n\n\n\n Born to bridge this gap, Euleria Health<\/a><\/strong> is an innovative startup<\/strong>, incubated by Bio4Dreams<\/strong>, that distributes clinically validated and certified medical devices and offers services to allow rehabilitation treatments \u2013 in both clinical and home settings, even remotely \u2013 for patients with musculoskeletal and neurological issues.<\/p>\n\n\n\n The company has developed a kit with wearable motion sensors<\/strong>. This kit is paired with a dedicated software platform<\/strong> that turns exercises into a videogame, improving patient adherence to rehabilitation. Additionally, it allows movement professionals to measure patients’ rehabilitation performance in real-time and guide their improvement<\/strong>.<\/p>\n\n\n\n For movement professionals who want to provide innovative support to rehabilitation patients \u2013 even in times of social distancing \u2013 we respond with Euleria.<\/em><\/p>\nDavid Tacconi<\/strong>, CEO & Co-founder, Euleria<\/cite><\/blockquote>\n\n\n\n \ud83d\udcb8 Euleria Health has closed a capital increase round<\/strong> to support its scale-up, marking the beginning of a new growth phase to be led by the new CEO, Dr. Paolo Girardi. At the same time, the incubation period at Bio4Dreams comes to an end, although the company remains in the portfolio as a participated entity. Read the news<\/strong><\/a><\/p>\n\n\n\n \u26f5 Euleria Health’s euleria lab software was used for biomechanical assessments in the “PaS-Pronti a Salpare<\/a><\/strong>” study, conducted by IRCCS Istituto Ortopedico Rizzoli, investigating the feasibility of sailing as ergotherapy for patients with rare skeletal diseases.<\/p>\n\n\n\n \ud83d\udeec Euleria Health participated in AOCNR 2023<\/strong>, the fifth edition of the Asia-Oceania Congress of Neurorehabilitation held in Bangkok from December 13-16, 2023.<\/p>\n\n\n\n \ud83d\udcb8 Euleria Health launched its fundraising campaign<\/strong> on the CrowdFundMe <\/strong>platform, aiming to expand in the USA, consolidate in Europe and Asia, and enhance its software suites. The campaign quickly went into overfunding<\/strong>. \u2705 Bureau Veritas certified Euleria Health’s new devices (euleria lab, euleria home, and euleria mylink) as Class IIa Software as Medical Device<\/strong>, according to the new European MDR 745\/2017 regulation.<\/p>\n\n\n\n \ud83d\ude4b Euleria Health participated with its innovative solutions for rehabilitation and telerehabilitation at Wired Health 2023<\/strong>, the reference event for digital innovation in the health sector.<\/p>\n\n\n\n \ud83c\uddf9\ud83c\uddf7 Euleria Health welcomes IMCA <\/strong>\u2013 a Turkish company specialized in engineering solutions for aviation, transport, industry, and consumer electronics \u2013 and its subgroup Sense4Motion, specializing in motion capture, to its network of international distributors.<\/p>\n\n\n\n \ud83d\udcb8 Euleria Health closed a capital increase of 600,000 euros with the Brixia Group<\/strong>, a historic Brescia holding engaged in research, culture, art, and technological innovation.<\/p>\n\n\n\n \ud83e\udd1d In addition, Euleria Health and Movella<\/strong>, a world leader in motion detection and analysis systems, initiated a partnership to develop advanced and accessible rehabilitation solutions, usable from clinic to home.<\/p>\n\n\n\n \ud83c\udfc6 Euleria Health is one of 6 entities that won the Health&BioTech Accelerator program<\/strong>, a program coordinated by Deloitte Officine Innovazione focused on open innovation in healthcare and biotech.<\/p>\n\n\n\n \ud83c\udd95 Alongside the release of a new update for Kari Konnect, the app for mobile rehabilitation, Euleria Health published a new section on its website dedicated to the application<\/a>.<\/p>\n\n\n\n \ud83d\ude4b\u200d\u2640\ufe0f Euleria Health will participate with a stand (Pavilion 22, Stand B6) at Exposanit\u00e0<\/strong>, the international exhibition serving the health and care sectors, which this year will be held in Bologna from May 11-13, 2022.<\/p>\n\n\n\n \ud83d\udcb8 Euleria raised 900,000 euros in a capital increase with a|impact<\/strong> and Bio4Dreams <\/strong>together with Ferrox <\/strong>and I.A.C.E.R.<\/strong>, respectively leaders in rehabilitation instruments and home therapy electromedical devices. The goal is to develop innovative solutions for telerehabilitation. Concurrently, Euleria became “Euleria Health<\/strong>” with an international vision.<\/p>\n\n\n\n \ud83d\udc75 Euleria, in collaboration with Dedalus, is working on eCare-PCP<\/strong><\/a>, a European project aimed at developing innovative digital solutions for the prevention of frailty in the elderly.<\/p>\n\n\n\n \u26bd Euleria hosted the ACF Trento<\/strong> female soccer players to also create their motor identity cards. The athletes underwent various tests and, thanks to inertial sensors, it was possible to evaluate parameters such as balance, agility, strength, and speed.<\/p>\n\n\n\n \ud83d\udc68\u200d\ud83d\udcbb Released version 1.6<\/strong> of Kari<\/strong>, Euleria’s medical device dedicated to telerehabilitation: introduced more features dedicated to remote monitoring of the rehabilitation process and more freedom for the patient in choosing workouts through the dedicated free app.<\/p>\n\n\n\n \ud83c\udfe0 Inaugurated its new headquarters at Befactory in Rovereto<\/strong>, a technologically innovative and eco-sustainable context born from the Manifattura Project by Trentino Sviluppo S.p.A.<\/p>\n\n\n\n \u26bd 175 athletes<\/strong> from A.C. Trento 1921<\/strong> were involved to test new devices to test balance, strength, speed, and agility of the lower limbs. Watch the video<\/a>.<\/p>\n\n\n\n \u270c\ufe0f The Kari4COVID-19 project entered Phase 2 of testing, involving orthopedic and sports cases thanks to three new rehabilitation centers<\/strong>: Flexor Lab (PG), CS F-Medical Group (FR), Studio Medico Kinesis (VA). Over 60 new video-exercises<\/strong> have been added to the telerehabilitation programs, and currently, Euleria is distributing the Kari device to 50 new patients<\/strong>. See the Phase 2 video here<\/a>.<\/p>\n\n\n\n \ud83d\udcb8 Following the Kari4COVID-19 project \u2013 dedicated to promoting COVID-19 technologies in Trentino as part of the third call by Fondazione VRT \u2013 the Foundation reaffirmed its confidence in Euleria<\/strong>‘s mission, proclaiming it a winner also of a second funding<\/strong>, in the context of the “Innovation for Market Launch 2020” call, for the telemedicine, televisit, and telerehabilitation section.<\/p>\n\n\n\n \ud83d\udcc3 During the event presenting the results of the grants funded by Fondazione VRT<\/strong> during 2020, David Tacconi, CEO of Euleria, received certification from the Foundation for the Kari4Covid19<\/a> project.<\/p>\n\n\n\n \ud83c\udfc6 With the title of Best Startup 2020<\/strong>, Euleria<\/strong> won the first edition of LDV20<\/a> as part of RADAR, the event dedicated to entrepreneurial innovation by Sparkasse. Learn more<\/a>.<\/p>\n\n\n\n \ud83d\udcca The trial between July and August collected significant feedback from patients and therapists<\/strong> about Kari. The results were presented on October 9, 2020, in Trento, at the Fondazione Caritro. Kari achieved an average usability<\/strong> SUS (System Usability Scale) score<\/strong> of 65.55, considered optimal<\/strong>. The device was appreciated by therapists<\/strong> for supporting patient motivation and maintaining therapy over time. See the feedback videos<\/a> and the press release<\/a>.<\/p>\n\n\n\n \ud83d\udd00 Launch of Telerehab<\/strong>, an online platform for matching supply and demand in remote rehabilitation. Movement professionals and patients can propose and seek rehabilitation solutions and pathways.<\/p>\n\n\n\n \u2699 The Kari trial began involving 50 patients<\/strong> equipped with the device with the support of the A.T.S.M. Centro Franca Martini in Trento.<\/p>\n\n\n\n \ud83d\udca1 Euleria obtained funding through the third call by FondazioneVRT<\/a> for promoting COVID-19 technologies in Trentino, thanks to the Kari4COVID-19<\/strong> project. This project also involves the Bruno Kessler Foundation (FBK)<\/a> and consists of a portable device for remote rehabilitation of vulnerable individuals<\/strong>, with anxiety and stress management through a pulse oximeter. The system will soon be tested at the A.T.S.M. Franca Martini<\/a>.<\/p>\n\n\n\n \ud83d\udcd7 Learn more about<\/em> <\/a>Euleria<\/a> and other entities in our portfolio<\/a>.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" The startup offers innovative rehabilitation devices and services in both clinical and home settings, even remotely.<\/p>\n","protected":false},"author":2,"featured_media":11877,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1313],"tags":[],"class_list":["post-17506","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-portfolio"],"acf":[],"yoast_head":"\nEuleria Health and digital rehabilitation<\/h2>\n\n\n\n
Between sensors and software platforms<\/h3>\n\n\n\n
\n
![\"Startup](\"https:\/\/tecnologiehosting.it\/wp-content\/uploads\/kit_euleria_home-1024x576.jpg\")
Updates:<\/h3>\n\n\n\n
June <\/em>2024<\/h4>\n\n\n\n
May<\/em><\/em> 2024<\/h4>\n\n\n\n
December<\/em><\/em> 2023<\/h4>\n\n\n\n
November<\/em> <\/em>2023<\/h4>\n\n\n\n
\ud83d\udcf1 Released euleria mylink<\/a><\/strong>, the healthcare app for smartphones that digitizes and modernizes the connection between the patient and the professional throughout the recovery process.<\/p>\n\n\n\nSeptember<\/em><\/em> 2023<\/h4>\n\n\n\n
March<\/em><\/em> 2023<\/h4>\n\n\n\n
October<\/em><\/em> 2022<\/h4>\n\n\n\n
September<\/em><\/em> 2022<\/h4>\n\n\n\n
July<\/em><\/em> 2022<\/h4>\n\n\n\n
May <\/em>2022<\/h4>\n\n\n\n
April <\/em>2022<\/h4>\n\n\n\n
March <\/em>2022<\/h4>\n\n\n\n
January <\/em>2022<\/h4>\n\n\n\n
December <\/em>2021<\/h4>\n\n\n\n
November <\/em>2021<\/h4>\n\n\n\n
October <\/em>2021<\/h4>\n\n\n\n
September <\/em>2021<\/h4>\n\n\n\n
January <\/em>2021<\/h4>\n\n\n\n
December<\/em> 2020<\/h4>\n\n\n\n
November <\/em>2020<\/h4>\n\n\n\n
October <\/em>2020<\/h4>\n\n\n\n
September<\/em> 2020<\/h4>\n\n\n\n
July <\/em>2020<\/h4>\n\n\n\n
June <\/em>2020<\/h4>\n\n\n\n